Physician profile
Lewis Rubin
NPI 1457377780
$264,593.02
in general payments reported to CMS, 2019-2025
6 companies · $139K in 2025
The $139K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84K · 2020: $26K · 2021: $8,835 · 2022: $6,479 · 2025: $139K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $139K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $138,782.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $138,782.07 | 2025 | General - Therapies |
| Actelion Pharmaceuticals, Ltd | $118,387.43 | 2019-2022 | |
| Orphai Therapeutics INC. | $3,687.50 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $2,325.00 | 2022 | |
| Vectura Limited | $750.00 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $661.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lewis Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.